Navigation Links
Warner Chilcott Announces Earnings Release Date and Conference Call for Third Quarter 2009 Financial Results
Date:11/2/2009

ARDEE, Ireland, Nov. 2 /PRNewswire-FirstCall/ -- Warner Chilcott plc (Nasdaq: WCRX) announced today that it will issue its third quarter 2009 financial results prior to the market opening on Monday, November 9, 2009.

In addition to issuing a press release, the Company will host a conference call for all interested parties on Monday, November 9, 2009 at 8:00 AM (Eastern Time) to review the results. To participate in the call, please dial (888) 812-8595 in the United States and Canada or (913) 312-0645 internationally.

Investors and other interested parties may also access the conference call via a simultaneous audio webcast by visiting http://ir.wcrx.com and clicking on Events & Presentations.

A replay of the conference call will be available for two weeks following the call and can be accessed by dialing (888) 203-1112 within the United States and Canada or (719) 457-0820 internationally. The passcode for the replay is 8954946.

The Company

Warner Chilcott is a leading specialty pharmaceutical company currently focused on the women's healthcare, gastroenterology, dermatology and urology segments of the U.S. and Western European pharmaceuticals market. It is a fully integrated company with internal resources dedicated to the development, manufacturing and promotion of its products. WCRX-F

SOURCE Warner Chilcott plc


'/>"/>
SOURCE Warner Chilcott plc
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Warner Chilcott Files New Lawsuit for Infringement of LOESTRIN(R) 24 FE and FEMCON(R) FE Patents
2. Video: U.S. Department of Health and Human Services Joins Ad Council and Warner Bros. Pictures to Combat Childhood Overweight and Obesity
3. Warner Chilcott Acquires P&Gs Global Pharmaceuticals Business
4. Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2009 and Updates 2009 Full Year Guidance
5. Warner Chilcott Announces Receipt of Paragraph IV Certification Notices
6. Warner Chilcott Announces Earnings Release Date and Conference Call For Second Quarter 2009 Financial Results
7. Warner Chilcott to Hold 2009 Annual General Meeting of Shareholders and Special Court-Ordered Meeting of Shareholders
8. Warner Chilcott to Present at Wachovias 19th Annual Mid-Year Equity Conference
9. Senators Webb and Warner Vote to Protect Americas Kids From Tobacco
10. Warner Chilcott to Present at the Goldman Sachs 30th Annual Healthcare Conference
11. Warner Chilcott Announces FDA Acceptance of NDA Submission for Low Dose Oral Contraceptive
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:ARKRAY, Inc. Announces Partnership With scil animal care company for the SPOTCHEM(TM) EZ Analyzer 2Data Published in Muscle and Nerve Validates the Six-Minute Walk Test as an Outcome Measure in Duchenne Muscular Dystrophy 2Data Published in Muscle and Nerve Validates the Six-Minute Walk Test as an Outcome Measure in Duchenne Muscular Dystrophy 3Data Published in Muscle and Nerve Validates the Six-Minute Walk Test as an Outcome Measure in Duchenne Muscular Dystrophy 4Data Published in Muscle and Nerve Validates the Six-Minute Walk Test as an Outcome Measure in Duchenne Muscular Dystrophy 5Mylan Announces Settlement Agreement Related to Antidepressant Effexor XR(R) 2Warner Chilcott to Present at the Goldman Sachs 30th Annual Healthcare Conference 48171 1Video 3A CVS pharmacy Kicks Off 8th Annual ALS Fundraising Campaign in Stores Nationwide 48169 1Video 3A CVS pharmacy Kicks Off 8th Annual ALS Fundraising Campaign in Stores Nationwide 48169 2Video 3A CVS pharmacy Kicks Off 8th Annual ALS Fundraising Campaign in Stores Nationwide 48169 3New Nutrisystem Works 28TM 29 Offers Corporate America New Weapon in the Fight Against Obesity 48167 1New Nutrisystem Works 28TM 29 Offers Corporate America New Weapon in the Fight Against Obesity 48167 2New Nutrisystem Works 28TM 29 Offers Corporate America New Weapon in the Fight Against Obesity 48167 3New Nutrisystem Works 28TM 29 Offers Corporate America New Weapon in the Fight Against Obesity 48167 4